ENGN

3.89

2.75% -0.11

Handel nachbörslich: 3.85 -0.04 -1.03%

Engene Holdings Inc (ENGN)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$4.00

Offen:

$3.93

24-Stunden-Volumen:

13,389

Relative Volume:

0.17

Marktkapitalisierung:

$203.40M

Einnahmen:

Nettoeinkommen (Verlust:

$-103.21M

KGV:

-0.8456

EPS:

-4.6001

Netto-Cashflow:

$-26.70M

1W Leistung:

-2.75%

1M Leistung:

-21.10%

6M Leistung:

-57.11%

1J Leistung:

-73.57%

1-Tages-Spanne:

$3.71

$4.19

1-Wochen-Bereich:

$3.71

$4.39

52-Wochen-Spanne:

$3.50

$16.62

Engene Holdings Inc Stock (ENGN) Company Profile

Firmenname

Engene Holdings Inc

Sektor

Healthcare (1155)

Branche

Biotechnology (677)

Telefon

(514) 332-4888

Adresse

4868 RUE LEVY, SUITE 220, SAINT-LAURENT

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ENGN's Discussions on Twitter

Vergleichen Sie ENGN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ENGN Engene Holdings Inc	3.89	203.40M	0	-103.21M	-26.70M	-4.6001
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-18	Eingeleitet	Piper Sandler	Overweight
2025-02-14	Herabstufung	UBS	Buy → Neutral
2024-12-23	Eingeleitet	H.C. Wainwright	Buy
2024-11-27	Eingeleitet	Raymond James	Outperform
2024-11-18	Eingeleitet	JMP Securities	Mkt Outperform
2024-08-28	Eingeleitet	Oppenheimer	Outperform
2024-04-22	Eingeleitet	Wells Fargo	Overweight
2024-04-15	Eingeleitet	Guggenheim	Buy
2024-03-28	Eingeleitet	UBS	Buy
2024-03-08	Eingeleitet	Morgan Stanley	Overweight
2024-02-20	Eingeleitet	Leerink Partners	Outperform

Alle ansehen

Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten

Apr 23, 2025

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now? - Insider Monkey

Apr 23, 2025

Apr 21, 2025

(ENGN) Technical Data - news.stocktradersdaily.com

Apr 21, 2025

Apr 14, 2025

enGene (NASDAQ:ENGN) & Innate Pharma (OTCMKTS:IPHYF) Head-To-Head Survey - Defense World

Apr 14, 2025

Apr 10, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Receives Average Rating of “Buy” from Analysts - Defense World

Apr 10, 2025

Apr 05, 2025

Trend Tracker for (ENGN) - news.stocktradersdaily.com

Apr 05, 2025

Apr 04, 2025

Engene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Apr 04, 2025

enGene Expands Team with New Hires, Grants 144,650 Shares in Stock Options - Stock Titan

Apr 04, 2025

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance

Apr 04, 2025

Apr 01, 2025

Strategic Oncology Updates Coming: enGene CEO Headlines Stifel Healthcare Forum - Stock Titan

Apr 01, 2025

Mar 15, 2025

How the (ENGN) price action is used to our Advantage - news.stocktradersdaily.com

Mar 15, 2025

Mar 12, 2025

Promising Trajectory and Strong Financial Position Justify Buy Rating for enGene Holdings - TipRanks

Mar 12, 2025

enGene Holdings Insider Ups Holding During Year - Yahoo Finance

Mar 12, 2025

enGene Holdings Inc.'s (NASDAQ:ENGN) market cap dropped US$33m last week; individual investors who hold 38% were hit as were institutions - Simply Wall St

Mar 12, 2025

enGene’s (ENGN) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 12, 2025

enGene (NASDAQ:ENGN) Price Target Lowered to $34.00 at Morgan Stanley - Defense World

Mar 12, 2025

Mar 11, 2025

Engene stock holds Buy rating, $25 target from H.C. Wainwright - Investing.com

Mar 11, 2025

Engene stock holds Buy rating, $25 target from H.C. Wainwright By Investing.com - Investing.com South Africa

Mar 11, 2025

enGene Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace

Mar 11, 2025

Mar 10, 2025

enGene Holdings Inc. SEC 10-Q Report - TradingView

Mar 10, 2025

enGene Reports Q1 Results: Strong Cash Position Funds Global Trial Expansion - StockTitan

Mar 10, 2025

Mar 04, 2025

Trading (ENGN) With Integrated Risk Controls - Stock Traders Daily

Mar 04, 2025

enGene to Participate in the Leerink Partners Global Healthcare Conference - Business Wire

Mar 04, 2025

What Will enGene Reveal? CEO's Upcoming Fireside Chat at Major Healthcare Conference - Stock Titan

Mar 04, 2025

Feb 27, 2025

Lumira Ventures Portfolio Company enGene (Nasdaq:ENGN) Debuts as Publicly Traded Genetic Medicines Company - ACCESS Newswire

Feb 27, 2025

enGene Holdings Inc.: Unknown Company Which Looks Like A Catch (NASDAQ:ENGN) - Seeking Alpha

Feb 27, 2025

Feb 25, 2025

Financial Contrast: enGene (NASDAQ:ENGN) versus iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Feb 25, 2025

Feb 22, 2025

(ENGN) On The My Stocks Page - Stock Traders Daily

Feb 22, 2025

Vontobel Holding Ltd. Makes New $69,000 Investment in enGene Holdings Inc. (NASDAQ:ENGN) - Defense World

Feb 22, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Feb 22, 2025

Feb 20, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Given Average Rating of “Buy” by Brokerages - Defense World

Feb 19, 2025

Feb 18, 2025

Piper Sandler sets $26 target on Engene shares with Overweight rating - Investing.com Australia

Feb 18, 2025

This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Feb 18, 2025

Buy Rating for enGene Holdings: Strategic Positioning and Growth Potential in NMIBC Market - TipRanks

Feb 18, 2025

Piper Sandler Initiates Coverage on enGene Holdings With Overweight Rating, $26 Price Target - Marketscreener.com

Feb 18, 2025

Piper Sandler sets $26 target on Engene shares with Overweight rating By Investing.com - Investing.com South Africa

Feb 18, 2025

Feb 17, 2025

Analyzing Ratios: enGene Holdings Inc (ENGN)’s Financial Story Unveiled - The Dwinnex

Feb 17, 2025

Feb 16, 2025

enGene (NASDAQ:ENGN) Stock Rating Lowered by UBS Group - Defense World

Feb 16, 2025

Feb 15, 2025

enGene (NASDAQ:ENGN) Downgraded to Neutral Rating by UBS Group - MarketBeat

Feb 15, 2025

Feb 14, 2025

Sector Update: Health Care -February 14, 2025 at 03:41 pm EST - Marketscreener.com

Feb 14, 2025

EnGene Holdings Shares Fall After UBS Downgrade -February 14, 2025 at 02:55 pm EST - Marketscreener.com

Feb 14, 2025

UBS Downgrades enGene Holdings to Neutral From Buy, Cuts Price Target to $7 From $34 - Marketscreener.com

Feb 14, 2025

enGene downgraded to Neutral from Buy at UBS - TipRanks

Feb 14, 2025

Feb 11, 2025

(ENGN) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Feb 11, 2025

Feb 07, 2025